What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Myocardial infarction
His primary scientific interests are in Internal medicine, Cardiology, Pravastatin, Myocardial infarction and Surgery.
His study in Internal medicine focuses on Heart failure, Risk factor, Prospective cohort study, Heart disease and Stroke.
His work investigates the relationship between Cardiology and topics such as Physical therapy that intersect with problems in Circulatory system, National Cholesterol Education Program, Comorbidity and Quality of life.
His work is dedicated to discovering how Pravastatin, Body surface area are connected with Kidney, Creatinine and Acute coronary syndrome and other disciplines.
He has included themes like Diabetes mellitus and Epidemiology in his Myocardial infarction study.
His work in Surgery covers topics such as Heart Protection Study which are related to areas like JUPITER trial and Lipid hypothesis.
His most cited work include:
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (6962 citations)
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2750 citations)
- West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials (1513 citations)
What are the main themes of his work throughout his whole career to date?
Stuart M. Cobbe spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Heart failure and Surgery.
His Internal medicine research focuses on subjects like Endocrinology, which are linked to Endocardium.
In his study, which falls under the umbrella issue of Cardiology, Ventricle is strongly linked to Anesthesia.
His Myocardial infarction research integrates issues from Placebo and Emergency medicine.
His study in Heart failure is interdisciplinary in nature, drawing from both T wave alternans, Sudden death, Atrial fibrillation and Intensive care medicine.
His Pravastatin study integrates concerns from other disciplines, such as Stroke and Clinical trial.
He most often published in these fields:
- Internal medicine (68.06%)
- Cardiology (53.23%)
- Myocardial infarction (19.39%)
What were the highlights of his more recent work (between 2006-2016)?
- Internal medicine (68.06%)
- Cardiology (53.23%)
- Heart failure (17.49%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cardiology, Heart failure, Myocardial infarction and Stroke are his primary areas of study.
The study incorporates disciplines such as Diabetes mellitus, Endocrinology and Surgery in addition to Internal medicine.
His Surgery research incorporates themes from Body mass index and Cohort study.
His work on Ejection fraction is typically connected to In patient as part of general Heart failure study, connecting several disciplines of science.
His Myocardial infarction research includes themes of Anesthesia, Randomized controlled trial and Action potential duration.
His Stroke study combines topics from a wide range of disciplines, such as Epidemiology, Lower risk, Quality of life, Physical therapy and Pravastatin.
Between 2006 and 2016, his most popular works were:
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis (1484 citations)
- The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease (727 citations)
- Smoke-free legislation and hospitalizations for acute coronary syndrome (377 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cardiology
His primary areas of investigation include Internal medicine, Cardiology, Stroke, Surgery and Prospective cohort study.
His Internal medicine research incorporates elements of Diabetes mellitus and Endocrinology.
Cardiology is represented through his Heart failure and Heart disease research.
His research integrates issues of Lower risk, Physical therapy, Quality of life and Myocardial infarction in his study of Stroke.
His work focuses on many connections between Myocardial infarction and other disciplines, such as Pravastatin, that overlap with his field of interest in Statin.
The Surgery study combines topics in areas such as Brain damage and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
